Diagnosis is primarily cytological, hinging on the classic “starry sky” appearance, alongside immunophenotyping that shows tumor cells positive for B‐cell markers (CD19, CD20, CD22, CD79a, CD38, PAX5) and germinal‐center markers (CD10, BCL6). The gene discussed is CD22; the disease is neoplasm.